Exenatide, sold under the brand name Byetta among others, is a medication used to treat type 2 diabetes. It is used together with diet, exercise, and...

produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended release). In 1987, Amylin Pharmaceuticals was co-founded...

the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered...

injection. Exenatide also slows the emptying of the stomach and causes a decrease in appetite, contributing to weight loss. The antidiabetic exenatide (Byetta)...

the risk of thrombosis. It is an antagonist of glycoprotein IIb/IIIa. Exenatide is a 39-amino-acid peptide that is a synthetic version of exendin-4, a...

pancreatitis including metformin, but glucagon-like peptide-1 mimetics such as exenatide are more strongly associated with pancreatitis by promoting inflammation...

version of exendin-4 called exenatide. In 2002, Eli Lilly entered into an alliance with Amylin to further develop exenatide and secure official approval...

with liraglutide 1.8 mg compared to insulin glargine, 0.33% more than exenatide 10 μg twice daily, sitagliptin and rosiglitazone. In a randomized controlled...

K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...

principally act as agonists of the GLP-1 receptor and are thus insulinotropic. Exenatide was the first drug in this class to be used in the treatment of type 2...